Nordic RBC Group

SATISFY

—

by

Andreas Glenthøj
in
  • Patient group: RBC membranopathies (spherocytosis, stomatocytosis), congenital dyserythropoietic anemia type II
  • Sponsor: EuroBloodNet Association
  • ID: NCT05935202
  • Details: https://clinicaltrials.gov/study/NCT05935202
  • Trial site: Rigshospitalet, Copenhagen, Denmark
  • Nordic Investigator: Andreas Glenthøj, Rigshospitalet, Copenhagen, Denmark (andreas.glenthoej@regionh.dk)